Pediatric preventive vaccinations are critical interventions to safeguard children from serious infectious diseases. These vaccines are administered during childhood to stimulate the immune system, creating a protective response against specific pathogens. Common pediatric vaccines include those against measles, mumps, rubella (MMR), diphtheria, tetanus, pertussis (DTaP), polio, hepatitis B, Haemophilus influenzae type b (Hib), and influenza. Vaccination schedules are carefully designed to ensure optimal protection at different stages of childhood. Pediatric vaccines not only shield individual children from potentially severe illnesses but also contribute to community immunity, protecting those unable to receive vaccines due to medical reasons. Herd immunity is crucial for preventing outbreaks of vaccine-preventable diseases. Vaccination has led to the near-eradication of certain diseases, such as polio and smallpox, and has significantly reduced the incidence of others. Ongoing research focuses on developing new vaccines, improving existing ones, and addressing vaccine hesitancy to maximize the impact of pediatric preventive vaccinations on child health globally.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States